Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Palliative Medicine
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Rees, E.
Right arrow Articles by A'Hern, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rees, E.
Right arrow Articles by A'Hern, R.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Cancer
*Palliative Care
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

The use of the Edmonton Symptom Assessment Scale (ESAS) within a palliative care unit in the UK

Elizabeth Rees

Department of Palliative Medicine, Royal Marsden NHS Trust, London and Surrey

Janet Hardy

Julie Ling

Karen Broadley

Roger A'Hern

Department of Palliative Medicine, Royal Marsden NHS Trust, London and Surrey

The Edmonton Symptom Assessment scale (ESAS) was used on 1004 occasions to assess 71 patients with advanced malignant disease admitted to a palliative care unit in the UK over a six-week period. The median length of inpatient stay was eight days (range 1–36) and the median survival from start of ESAS to death was 16 days (range 2–202). Across all patients there was a trend towards worsening symptom scores over the first five days from admission with a significant deterioration in appetite scores. When scores were analysed retrospectively over five days according to outcome (death–group 1, or discharge–group 2) there was a significant improvement in pain scores in group 2 but no change in overall score, and a significant deterioration in activity, drowsiness and appetite in group 1 with no change in overall score. ESAS did not seem an appropriate tool in this group of patients as the total symptom scores were so often biased by the inevitable increase in individual symptom scores immediately prior to death.

Key Words: neoplasms • outcome and process assessment (health care) • palliative care • quality of life

Palliative Medicine, Vol. 12, No. 2, 75-82 (1998)
DOI: 10.1191/026921698674135173


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
AM J HOSP PALLIAT CAREHome page
W. Lasheen, D. Walsh, K. Hauser, T. Gutgsell, and M. T. Karafa
Symptom Variability During Repeated Measurement Among Hospice Patients With Advanced Cancer
American Journal of Hospice and Palliative Medicine, October 1, 2009; 26(5): 368 - 375.
[Abstract] [PDF]


Home page
Palliat MedHome page
C. Saxby, R. Ackroyd, S. Callin, C. Mayland, and S. Kite
How should we measure emesis in palliative care?
Palliative Medicine, July 1, 2007; 21(5): 369 - 383.
[Abstract] [PDF]


Home page
JCOHome page
J. Kirkova, M. P. Davis, D. Walsh, E. Tiernan, N. O'Leary, S. B. LeGrand, R. L. Lagman, and K. M. Russell
Cancer Symptom Assessment Instruments: A Systematic Review
J. Clin. Oncol., March 20, 2006; 24(9): 1459 - 1473.
[Abstract] [Full Text] [PDF]


Home page
J Natl Cancer Inst MonogrHome page
J. A. Paice
Assessment of Symptom Clusters in People With Cancer
J Natl Cancer Inst Monographs, July 1, 2004; 2004(32): 98 - 102.
[Abstract] [Full Text] [PDF]


Home page
Palliat MedHome page
R M Pickering
Statistical aspects of measurement in palliative care
Palliative Medicine, June 1, 2002; 16(4): 359 - 364.
[PDF]


Home page
Palliat MedHome page
L. Radbruch, R. Sabatowski, G. Loick, I. Jonen-Thielemann, M. Kasper, B. Gondek, K. A Lehmann, and I. Thielemann
Cognitive impairment and its influence on pain and symptom assessment in a palliative care unit: development of a Minimal Documentation System
Palliative Medicine, June 1, 2000; 14(4): 266 - 276.
[Abstract] [PDF]


Home page
Palliat MedHome page
N Pratheepawanit, M S Salek, and I G Finlay
The applicability of quality-of-life assessment in palliative care: comparing two quality-of-life measures
Palliative Medicine, June 1, 1999; 13(4): 325 - 334.
[Abstract] [PDF]


Home page
Palliat MedHome page
C Salisbury, N Bosanquet, E K Wilkinson, P J Franks, S Kite, M Lorentzon, and A Naysmith
The impact of different models of specialist palliative care on patients' quality of life: a systematic literature review
Palliative Medicine, January 1, 1999; 13(1): 3 - 17.
[Abstract] [PDF]